Masong, Harmelene C.

HRN: 10-67-36  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/30/2022
FLUCONAZOLE 2MG/ML, 100ML (VIAL)
09/30/2022
10/07/2022
IV
276mg
Q24Hrs
Tc Fungal Infection
Waiting Final Action 

Indication:  ProphylaxisEmpiric    Type of Infection:  Urinary TractEye, Ear, Nose, Throat, & Mouth    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: